Background Although osteoporosis is a well known side effect of long term prednisolone, the effects of a short course are less clear. Biochemical markers of bone turnover were therefore studied in 10 men with chronic obstructive airways disease who required assessment of "steroid reversibility" (mean age 65 years, mean FEV, Although increases in 24 hour urinary calcium excretion have been reported during the first four weeks of corticosteroid treatment,'0 1' changes in urinary hydroxyproline excretion, an indicator of increased bone resorption, are less well established."
,ug/l), nor did the area under the curve (-O4 (13 5); NS, 95% confidence limits -100, 9-2).
There were no significant changes in urea, creatinine, calcium, phosphate, electrolytes, glucose, proteins, or liver function. All 10 patients had normal thyroid function and vitamin D concentrations. In one baseline calcium and parathyroid hormone concentrations were modestly increased (2-73 mmol/l and 8-5 pmol/l).
Discussion
In this study substantial increases in the fasting urinary hydroxyproline:creatinine ratio occurred during two to four weeks' treatment with prednisolone 20 mg daily. This ratio is a well validated marker of bone resorption and correlates highly with both kinetic and histological indicators of total bone resorption.3 14 An increased ratio usually reflects high bone turnover, as in Paget's disease of bone, perimenopausal bone loss, or hyperparathyroidism."3 14 Gennari found a 77% increase in the total hydroxyproline:creatinine ratio after 30 days of prednisone 20 mg but only a 30% increase after deflazocort 30 mg; the calcium:creatinine ratio rose by 73% and 29%." No change in the hydroxyproline:creatinine ratio was seen in nine normal subjects after only five days' prednisone 20 mg twice daily,'9 but we are not aware of studies of longer duration in normal subjects. After two and four weeks' prednisolone treatment, however, a substantial rise in the hydroxyproline:creatinine ratio was seen in our patients. Ali et al found a 46% increase in the hydroxyproline:creatinine ratio after four weeks of inhaled beclomethasone dipropionate 2000pg daily in normal men and a small but significant fall in serum alkaline phosphatase of 7-4%. Substantial changes had likewise occurred after only two weeks. 2 (31) 81 (30) 113 (40) Osteocalcin (Mg/1)
a reduction in the fasting urinary calcium: creatinine ratio in 10 normal adults given inhaled budesonide 2-4 mg daily for seven days but did not measure hydroxyproline. 20 We can therefore confirm that short courses of prednisolone produce substantial resorption of bone. Several mechanisms may play a part, including a reduction in the proliferation of osteoblast precursors and osteoblast activity and increases in the activity of osteoclasts, the secretion of parathyroid hormone, and the sensitivity of the skeleton to vitamin D3; the absorption of calcium and phosphate by the gut and reabsorption by the kidney are also reduced.32122 Serum alkaline phosphatase fell after two and four weeks of prednisolone, indicating a reduction in net bone formation, without changes in serum calcium or phosphate. Serum osteocalcin concentrations were about half the normal in cross sectional studies of asthmatic patients receiving long term glucocorticoid treatment.2324 In normal subjects given 40 mg prednisone for five days osteocalcin fell by 75%.'9 The lack of change in osteocalcin in our patients was therefore unexpected, but may have reflected their relatively low concentrations before they started taking prednisolone.
Short courses of corticosteroids used in the assessment or treatment of airflow obstruction therefore increase bone resorption and inhibit bone formation and may contribute to long term loss of bone mass. This may be particularly relevant in women already at risk of osteoporosis. Furthermore, such short courses may contribute to the reduction in total body calcium observed in asthmatic patients taking low dose inhaled corticosteroids.2526
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